Featured
Featured Videos
Kevin Davies, PhD, editorial director and Julianna LeMieux, PhD, deputy editor in chief at GEN have been on the ground of the ASGCT meeting for a few days—in the talks, expo hall, and press room, covering as much of the news as they can. In this video, filmed from the conference floor, Kevin and Julianna chat about the talks that they have been blown away by—from Kiran Musunuru and Tippi MacKenzie to a glimpse of what is going on at Nava Therapeutics.
The News from New Orleans: GEN‘s Takeaways from ASGCT
The American Society of Gene and Cell Therapy (ASGCT) meeting is off and running in New Orleans! Kevin Davies, PhD, editorial director and Julianna LeMieux, PhD, deputy editor in chief at GEN are on the ground—in the talks, expo hall, and press room, covering as much of the news as they can.
Biotech and Beignets: The News from Day One of ASGCT
The month of May brings with it spring and an abundance of new growth and life. In this issue of GEN we celebrate the abundance of stories highlighting progress and growth in the field of cell and gene therapy in a special American Society of Gene & Cell Therapy (ASGCT) issue. Ahead of the 28th ASGCT meeting, GEN spoke with the organization’s leadership about their perspectives on scientific advances, new tools, and the current state of funding constraints. Other topics in this issue include the ongoing efforts in CAR T-cell therapy, innovative delivery techniques, including high-tech nanoparticles and electroporation devices, and progress in improving AAV-based gene therapies. Additionally, the magazine includes a story discussing how current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products. Finally, the May issue also includes “The Top 10 Best-Selling Gene Therapies.”
